Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 February 2020 | Story Valentino Ndaba
Charné Ferreira
Kovsies is proud of Charné Ferreira one of just 12 candidates to be placed on the Honours Roll of the South African Institute of Chartered Accountants.

The South African Institute of Chartered Accountants (SAICA) recently announced the candidates who wrote and successfully met the requirements of the Assessment of Professional Competence (APC) examination. One of 2 024 names released was that of Charné Ferreira, a University of the Free State (UFS) alumna.

Ferreira was among 3 560 candidates who attempted the APC in November 2019. This gruelling part of her journey to becoming a Chartered Accountant (CA) was a culmination of many years of intensive education and training.

Now a Senior Associate at PricewaterhouseCoopers, Ferreira reflects on how her career started with the decision to take Accounting as a subject in high school. In her second- and third-year as a Kovsie student, Ferreira challenged herself to become a tutor. This gave her the opportunity to secure a position as an Academic Trainee at the UFS School of Accountancy.

Recognising outstanding performance
Not only did Ferreira pass the most demanding Chartered Accounting test in South Africa, but she excelled and earned a place on the institute’s prestigious APC Honours Roll. SAICA honours only 12 exceptional candidates for their aptitude and skill. 

Excellence to match market demands
According to Freeman Nomvalo, CEO of SAICA: “In many ways this is the toughest exam because it requires aspirant Chartered Accountants (CASA) to apply their technical academic knowledge from multiple disciplines to a single but complex real-life business case study. To pass, candidates must demonstrate high levels of the skills employers have told us they want in the next generation of CAs (SA).

“Succeeding at this final test of professional competence requires advanced levels of critical thinking, the ability to work with technology, and the capacity to assimilate new information under pressure over a five-day period which culminates in an eight-hour assessment. It’s gruelling but it’s exactly the kind of challenge successful candidates will soon face as qualified CAs (SA),” added Nomvalo.

A word to the wise
Looking back at the building blocks that led her to this point, Ferreira shared invaluable advice for future candidates. “Ask for help, speak up if you do not know, speak up if you are drowning in stress. Your career is not a sprint, it is okay if you fail, as long as you get up again and the most important thing is, make time to rest, do not be so hard on yourself,” she said.

In congratulating Ferreira and the other UFS alumni who passed the 2019 Assessment of Professional Competence, Prof Frans Prinsloo, Director: School of Accountancy, also paid tribute to the excellent work of the UFS academics in the School who play a vital role in developing the knowledge, skills and values of the next generation of accounting professionals. “These results attest to the quality of the Chartered Accountancy education offered by the UFS,” he said.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept